Neuroscience & Psychiatry | Allucent
Home  /  Therapeutic Expertise  /  Neuroscience & Psychiatry

Neuroscience & Psychiatry

Helping you make a dramatic impact on quality of life for those with neurological disorders

SCROLL

Neurological clinical trials face a range of unique challenges due to the complexity of the peripheral and central nervous systems, the intricate nature of neurological diseases, and the complexity of measuring neurological and psychiatric outcomes. Memory and other cognitive impairments, behavioural abnormalities, reduced motor capability, and sensory deficiencies, all create a high burden on patients as well as the caregivers on whom many are dependent.

For more than 30 years, Allucent has been at the forefront of neuroscience clinical development projects worldwide, involving over 140 clinical trials in more than 40 indications, bringing hope and breakthrough treatments to countless patients suffering from neurological disorders.

Allucent Center of Expertise (ACE): Neuroscience & Psychiatry

Neurological clinical development requires the specialized services and solutions of a neuroscience CRO to ensure a comprehensive regulatory strategy, a robust study design, effective patient-focused recruitment strategies, and industry-leading technology solutions.
 
ACE: Neuroscience and Psychiatry offers cross-functional expertise through clinical pharmacology experts, regulatory strategists, biostatistical consultants, medical affairs, and operational experts, who share your deep commitment to developing therapies for neurodegenerative, neurological, rare neurological, pain, and psychiatric conditions.

Click icons for more information:

Our team has developed deep and wide expertise in neuroscience via our experiences conducting research and advancing clinical trials for various indications that include the treatment of addiction disorders, pain disorders, Alzheimer’s disease, Huntington’s disease, psychosis, and seizure disorders. This expertise has allowed Allucent to gain the trust of our partners developing products for rare and other types of diseases, as well as to best position them for success when engaging global regulatory authorities at various stages of the drug development life cycle.

Marcus Delatte

VP, Regulatory Strategy

Depth of Neuroscience & Psychiatric Experience

Allucent has conducted a wide range of neuroscience clinical trials, from early phase trials where dose escalation was dependent on repeated CSF sampling and neuroimaging, to worldwide Phase III trials with various interim analyses or adaptive designs.

140+

Studies

1,950+

Sites

15,450+

Patients

680+

Consulting Projects

All-time years of experience

With global breadth and depth across a wide range of neuroscience & psychiatric indications, Allucent partners with biotech companies to bring innovative therapies to light.

Meet Some of Our Neuroscience & Psychiatric Drug Experts

Lisa Benincosa, PhD

SVP,
Clinical Pharmacology Strategy

Lisa Benincosa, PhD - LinkedIn Page

Marcus Delatte, PhD

VP,
Regulatory Strategy

Marcus Delatte, PhD - LinkedIn Page

Gilad Rosenberg, MD, MSc

Executive Medical Director, Therapeutic Medical Area Lead, Neuroscience

Gilad Rosenberg, MD, MSc - LinkedIn Page

Maria Seivane

Global Operations Head,
Neuroscience

Maria Seivane - LinkedIn Page

Related Content

Additional Resources

Partner With the A-Team

Let us know how we can help you bring new therapies to light. Get in touch to get started.

Join the A-Team

Want to help small and mid-sized biotech companies change the therapeutic landscape?

Subscribe to our monthly newsletter